ExodusPoint Capital Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-415,113
| Closed | -$6.49M | – | 1766 |
|
|
2024
Q3 | $6.49M | Buy |
415,113
+338,808
| +444% | +$5.3M | 0.04% | 289 |
|
|
2024
Q2 | $1.31M | Sell |
76,305
-156,406
| -67% | -$2.68M | 0.01% | 814 |
|
|
2024
Q1 | $3.64M | Buy |
232,711
+50,472
| +28% | +$789K | 0.03% | 403 |
|
|
2023
Q4 | $2.72M | Buy |
182,239
+32,111
| +21% | +$479K | 0.02% | 450 |
|
|
2023
Q3 | $2.43M | Buy |
150,128
+138,666
| +1,210% | +$2.24M | 0.02% | 583 |
|
|
2023
Q2 | $476K | Buy |
+11,462
| New | +$476K | ﹤0.01% | 1293 |
|
|
2022
Q3 | – | Sell |
-33,303
| Closed | -$2.32M | – | 2112 |
|
|
2022
Q2 | $2.32M | Buy |
+33,303
| New | +$2.32M | 0.03% | 682 |
|
|
2022
Q1 | – | Sell |
-18,975
| Closed | -$1.43M | – | 2468 |
|
|
2021
Q4 | $1.43M | Buy |
18,975
+9,816
| +107% | +$737K | 0.01% | 864 |
|
|
2021
Q3 | $1.06M | Buy |
9,159
+4,234
| +86% | +$492K | 0.01% | 949 |
|
|
2021
Q2 | $1.09M | Buy |
+4,925
| New | +$1.09M | 0.01% | 905 |
|
|
2021
Q1 | – | Sell |
-29,054
| Closed | -$5.03M | – | 2389 |
|
|
2020
Q4 | $5.03M | Sell |
29,054
-28,335
| -49% | -$4.9M | 0.05% | 223 |
|
|
2020
Q3 | $6.39M | Sell |
57,389
-13,430
| -19% | -$1.49M | 0.13% | 124 |
|
|
2020
Q2 | $4.2M | Buy |
70,819
+51,663
| +270% | +$3.06M | 0.11% | 180 |
|
|
2020
Q1 | $1.29M | Sell |
19,156
-18,903
| -50% | -$1.27M | 0.07% | 218 |
|
|
2019
Q4 | $3.21M | Buy |
38,059
+29,202
| +330% | +$2.46M | 0.06% | 195 |
|
|
2019
Q3 | $662K | Buy |
+8,857
| New | +$662K | 0.02% | 509 |
|